Sanguinarine suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma via inhibiting mTOR signaling

被引:3
作者
Yang Mengzhe [1 ]
Zhang Beibei [2 ]
Liang Zhenqiang [3 ]
Cheng Nannan [1 ]
Lu Anqiao [1 ]
Yang Jianyu [1 ]
Guo Xingzhe [1 ]
Bai Xianyu [1 ]
Huang Yuanjiao [4 ]
Jiao Aijun [5 ]
Xu Ning [6 ]
机构
[1] Guangxi Med Univ, Sch Basic Med Sci, Nanning 530021, Peoples R China
[2] Yunnan Univ, Inst Biomed Res, Kunming 650500, Yunnan, Peoples R China
[3] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Otolaryngol Head & Neck Surg, Nanning 530021, Peoples R China
[4] Guangxi Med Univ, Life Sci Inst, Nanning 530021, Peoples R China
[5] Guangxi Med Univ, Pharmaceut Coll, Nanning 530021, Peoples R China
[6] Guangxi Med Univ, Affiliated Hosp 5, Dept Neurol, Nanning 530021, Peoples R China
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; sanguinarine; TOR serine-threonine kinases; apoptosis; CANCER-CELLS; ANTICANCER DRUGS; PATHWAY; GROWTH; KINASE; PERSPECTIVES; RESISTANCE; TARGETS;
D O I
10.19852/j.cnki.jtcm.20220426.001
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
OBJECTIVE: To confirm the anti-NPC effect of sanguinarine (SA) through a series of wet experiments.METHODS: NPC cell viability was determined by proliferation experiment. Cell clone formation experiment, cell scratch test, transwell migration and invasion experiment and flow cytometry-based cell apoptosis assay were further performed. In addition, Western blotting was performed to investigate the cell signaling pathway. All the relevant experimental data were statistically processed using SPSS 16.0 software.RESULTS: The results showed that sanguinarine represented a time and dose dependent inhibition effects on NPC cell proliferation including the low differentiated CNE2 cells and high metastatic 5-8F cells, along with the cell cloning ability reduction. In addition, sanguinarine has a certain inhibitory effect on the invasion and migration of NPC cells. Mechanistically, sanguinarine displayed the anti-NPC effects mainly involved into the suppression of mTOR signaling and cell apoptosis, which is closely associated with the tumor growth and metastatic malignancy.CONCLUSIONS: Collectively, we discover that sanguinarine is a new high-efficiency anti-NPC monomer of Chinese medicine, with a value for the follow-up pre-clinical research.(c) 2022 JTCM. All rights reserved.
引用
收藏
页码:687 / 692
页数:6
相关论文
共 37 条
[1]   Anticancer potential of sanguinarine for various human malignancies [J].
Achkar, Iman W. ;
Mraiche, Fatima ;
Mohammad, Ramzi M. ;
Uddin, Shahab .
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (09) :933-950
[2]  
Ahmad N, 2000, CLIN CANCER RES, V6, P1524
[3]   Nasopharyngeal carcinoma [J].
Brennan, Bernadette .
ORPHANET JOURNAL OF RARE DISEASES, 2006, 1 (1)
[4]   The MAPK Pathway Across Different Malignancies: A New Perspective [J].
Burotto, Mauricio ;
Chiou, Victoria L. ;
Lee, Jung-Min ;
Kohn, Elise C. .
CANCER, 2014, 120 (22) :3446-3456
[5]  
Cao Su-Mei, 2011, Chin J Cancer, V30, P114
[6]   Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells [J].
Eid, Safaa Yehia ;
El-Readi, Mahmoud Zaki ;
Wink, Michael .
PHYTOMEDICINE, 2012, 19 (14) :1288-1297
[7]   Molecular targets and anticancer potential of sanguinarine-a benzophenanthridine alkaloid [J].
Galadari, Sehamuddin ;
Rahman, Anees ;
Pallichankandy, Siraj ;
Thayyullathil, Faisal .
PHYTOMEDICINE, 2017, 34 :143-153
[8]   Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance [J].
Gangemi, Rosaria ;
Paleari, Laura ;
Orengo, Anna Maria ;
Cesario, Alfredo ;
Chessa, Leonardo ;
Ferrini, Silvano ;
Russo, Patrizia .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (14) :1688-1703
[9]   Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives [J].
Gaziano, Roberta ;
Moroni, Gabriella ;
Buse, Cristina ;
Miele, Martino Tony ;
Sinibaldi-Vallebona, Paola ;
Pica, Francesca .
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 8 (01) :30-39
[10]   mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels [J].
Ghayad, Sandra E. ;
Bieche, Ivan ;
Vendrell, Julie A. ;
Keime, Celine ;
Lidereau, Rosette ;
Dumontet, Charles ;
Cohen, Pascale A. .
CANCER SCIENCE, 2008, 99 (10) :1992-2003